Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France

Cancer Epidemiology

Volumn 39, Issue 4, 2015, Pages 511-518

  Colonna, M ^a,b   Uhry, Z ^c,g   Guizard, A V ^b,h   Delafosse, P ^a,b   Schvartz, C ^b,i   Belot, A ^c,d,e,f,g,j   Grosclaude, P ^b,k  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b FRANCIM   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e UNIVERSITÉ DE LYON   (France)

^f UNIVERSITÉ LYON 1   (France)

^g LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^h CENTRE FRANÇOIS BACLESSE   (France)

ⁱ CLCC Jean Godinot ^*  (France)

^j IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^k Centre Hospitalier spécialisé   (France)

more..

Author keywords

Geographical distribution; Incidence; Net survival; Papillary thyroid cancer; Time trend

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAPILLARY THYROID CANCER; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; STANDARDIZED INCIDENCE RATIO; THYROID CARCINOMA; TREND STUDY; VERY ELDERLY; ADOLESCENT; CARCINOMA; INCIDENCE; REGISTER; RISK FACTOR; THYROID NEOPLASMS;

ADOLESCENT; ADULT; AGED; CARCINOMA; FEMALE; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; THYROID NEOPLASMS;

EID: 84938739403     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.04.015     Document Type: Article

References (47)

1. Kilfoy B.A., Zheng T., Holford T.R., Xuesong Han X., Mary H., Ward M.H., et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Cause Control 2009, 20:525-531.
2. Burgess J.R. Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 2002, 12:141-149.
3. Reynolds R., Weir J., Stockton D., Brewstert D., Sandep T., Strachan M. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol 2005, 62:156-162.
4. Colonna M., Guizard A.V., Schvartz C., Velten M., Raverdy N., Molinie F., et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Eur J Cancer 2007, 43:891-900.
5. Netea-Maier R.T., Aben K.K., Casparie M.K., den Heijer M., Grefte J.M., Slootweg P., et al. Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery. Int J Cancer 2008, 123:1681-1684.
6. Enewold L., Zhu K., Ron E., Marrogi A.J., Stojadinovic A., Peoples G.E., et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009, 18:784-791.
7. Zhu C., Zheng T., Kilfoy B.A., Han X., Ma S., Ba Y., et al. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid 2009, 19:1061-1066.
8. Cramer J.D., Fu P., Harth K.C., Margevicius S., Wilhelm S.M. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. Surgery 2010, 148:1147-1152.
9. Morris L.G., Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 2010, 200:454-461.
10. Dal Maso L., Lise M., Zambon P., Falcini F., Crocetti E., Serraino D., et al. Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects. Ann Oncol 2011, 22:957-963.
11. Husson O., Haak H.R., van Steenbergen L.N., Nieuwlaat W.A., van Dijk B.A., Nieuwenhuijzen G.A., et al. Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989. Endocr Relat Cancer 2013, 20:263-271.
12. Cancer Incidence in Five Continents 2013, Vol. X (electronic version). International Agency for Research on Cancer, Lyon, Available from http://ci5.iarc.fr, accessed on 08/04/2015.
13. Binder-Foucard F., Bossard N., Delafosse P., Belot A., Woronoff A.S., Remontet L., et al. French network of cancer registries (Francim). Cancer incidence and mortality in France over the 1980-2012 period: solid tumors. Rev Epidemiol Sante Publique 2014, 62:95-108.
14. Ward E.M., Jemal A., Chen A. Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation?. Future Oncol 2010, 6:185-188.
15. Ito Y., Nikiforov Y.E., Schlumberger M., Vigneri R. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol 2013, 9:178-184.
16. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-175.
17. Akaike H. Information theory and an extension of the maximum likelihood principle. Second international symposium on information theory 1973, 267-281. Budapest. E.D. Petrov, F. Csaki (Eds.).
18. Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med 2007, 2026:3018-3045.
19. Potthoff R.F., Whittinghill M. Testing for homogeneity: the Poisson distribution. Biometrika 1966, 53:183-190.
20. Roche L., Danieli C., Belot A., Grosclaude P., Bouvier A.M., Velten M., et al. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods. Int J Cancer 2013, 132:2359-2369.
21. Perme M.P., Stare J., Esteve J. On estimation in relative survival. Biometrics 2012, 68:113-120.
22. Corazziari I., Quinn M., Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004, 40:2307-2316.
23. Tchernobyl, 25 ans après Collection thématique 2011, IRSN, France, Available from http://www.irsn.fr/fr/connaissances/documents/irsn_livret_tchernobyl_2011.pdf.
24. Burgess J.R., Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 2006, 16:47-53.
25. Grodski S., Brown T., Sidhu S., Gill A., Robinson B., Learoyd D., et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 2008, 144:1038-1043.
26. Lise M., Franceschi S., Buzzoni C., Zambon P., Falcini F., Crocetti E., et al. Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis. Thyroid 2012, 22:27-34.
27. Li N., Du X.L., Reitzel L.R., Xu L., Sturgis E.M. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid 2013, 23:103-110.
28. Leenhardt L., Bernier M.O., Boin-Pineau M.H., Conte Devolx B., Maréchaud R., Niccoli-Sire P., et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 2004, 150:133-139.
29. Chen A.Y., Jemal A., Ward E.M. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009, 115:3801-3807.
30. Kovács G.L., Gonda G., Vadász G., Ludmány E., Uhrin K., Görömbey Z., et al. Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 2005, 15:152-157.
31. Valle L.A., Kloos R.T. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab 2011, 96:E109-E113.
32. Zheng T., Holford T.R., Chen Y., Ma J.Z., Flannery J., Liu W., et al. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. Int J Cancer 1996, 67:504-509.
33. Amphlett B., Lawson Z., Abdulrahman G.O., White C., Bailey R., Premawardhana L.D., et al. Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010. Thyroid 2013, 23:1470-1478.
34. Akslen L.A., Haldorsen T., Thoresen S.O., Glattre E. Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. Int J Cancer 1993, 53:183-187.
35. Dos Santos Silva I., Swerdlow A.J. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 1993, 67:330-340.
36. Lund E., Galanti M.R. Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: an analysis of birth cohorts. Cancer Cause Control 1999, 10:181-187.
37. Colonna M., Grosclaude P., Remontet L., Schvartz C., Mace-Lesech J., Velten M., et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 2002, 38:1762-1768.
38. Montanaro F., Pury P., Bordoni A., Lutz J.M. Swiss Cancer Registries Network. Unexpected additional increase in the incidence of thyroid cancer among a recent birth cohort in Switzerland. Eur J Cancer Prev 2006, 15:178-186.
39. Cardis E., Krewski D., Boniol M., Drozdovitch V., Darby S.C., Gilbert E.S., et al. Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. Int J Cancer 2006, 119:1224-1235.
40. Olaleye O., Ekrikpo U., Moorthy R., Lyne O., Wiseberg J., Black M., et al. Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol 2011, 268:899-906.
41. McNally R.J., Blakey K., James P.W., Gomez Pozo B., Basta N.O., Hale J. Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. Eur J Epidemiol 2012, 27:615-622.
42. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006, 295:2164-2167.
43. Dal Maso L., Bosetti C., La Vecchia C., Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Cause Control 2009, 20:75-86.
44. Clayton D., Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 1987, 6:469-481.
45. Londero S.C., Krogdahl A., Bastholt L., Overgaard J., Pedersen H.B., Hahn C.H., et al. Papillary thyroid carcinoma in Denmark, 1996-2008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort. Thyroid 2015, 25:78-84.
46. Engholm G., Ferlay J., Christensen N., Kejs A.M.T., Johannesen T.B., Khan S., et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries version 7.0 (17.12.2014) 2014, Association of the Nordic Cancer Registries, Danish Cancer Society, Available from http://www.ancr.nu, accessed on 08/04/2015.
47. Jansen L., Castro F.A., Gondos A., Krilaviciute A., Barnes B., Eberle A., et al. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer 2015, 136:2649-2658.